Valacyclovir
The global Valacyclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valacyclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valacyclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valacyclovir include GSK, Mylan Pharmaceuticals, Cobalt Laboratories (Allergan), Sorres Pharma, Sivem Pharmaceuticals, Remedy Repack, Apotex Corporation, Auro Pharma and Biomed Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valacyclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir.
Report Scope
The Valacyclovir market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valacyclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Segment by Type
Tablets
Capsule
Granules
Segment by Application
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valacyclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Valacyclovir Market Overview
1.1 Product Overview and Scope of Valacyclovir
1.2 Valacyclovir Segment by Type
1.2.1 Global Valacyclovir Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Granules
1.3 Valacyclovir Segment by Application
1.3.1 Global Valacyclovir Market Value by Application: (2024-2030)
1.3.2 Herpes Zoster Virus
1.3.3 Herpes Simplex Virus
1.3.4 EB Virus
1.3.5 Cytomegalovirus
1.4 Global Valacyclovir Market Size Estimates and Forecasts
1.4.1 Global Valacyclovir Revenue 2019-2030
1.4.2 Global Valacyclovir Sales 2019-2030
1.4.3 Global Valacyclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valacyclovir Market Competition by Manufacturers
2.1 Global Valacyclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valacyclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valacyclovir Average Price by Manufacturers (2019-2024)
2.4 Global Valacyclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valacyclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valacyclovir, Product Type & Application
2.7 Valacyclovir Market Competitive Situation and Trends
2.7.1 Valacyclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valacyclovir Players Market Share by Revenue
2.7.3 Global Valacyclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valacyclovir Retrospective Market Scenario by Region
3.1 Global Valacyclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valacyclovir Global Valacyclovir Sales by Region: 2019-2030
3.2.1 Global Valacyclovir Sales by Region: 2019-2024
3.2.2 Global Valacyclovir Sales by Region: 2025-2030
3.3 Global Valacyclovir Global Valacyclovir Revenue by Region: 2019-2030
3.3.1 Global Valacyclovir Revenue by Region: 2019-2024
3.3.2 Global Valacyclovir Revenue by Region: 2025-2030
3.4 North America Valacyclovir Market Facts & Figures by Country
3.4.1 North America Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valacyclovir Sales by Country (2019-2030)
3.4.3 North America Valacyclovir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valacyclovir Market Facts & Figures by Country
3.5.1 Europe Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valacyclovir Sales by Country (2019-2030)
3.5.3 Europe Valacyclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valacyclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valacyclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Valacyclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valacyclovir Market Facts & Figures by Country
3.7.1 Latin America Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valacyclovir Sales by Country (2019-2030)
3.7.3 Latin America Valacyclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valacyclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Valacyclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valacyclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valacyclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valacyclovir Sales by Type (2019-2030)
4.1.1 Global Valacyclovir Sales by Type (2019-2024)
4.1.2 Global Valacyclovir Sales by Type (2025-2030)
4.1.3 Global Valacyclovir Sales Market Share by Type (2019-2030)
4.2 Global Valacyclovir Revenue by Type (2019-2030)
4.2.1 Global Valacyclovir Revenue by Type (2019-2024)
4.2.2 Global Valacyclovir Revenue by Type (2025-2030)
4.2.3 Global Valacyclovir Revenue Market Share by Type (2019-2030)
4.3 Global Valacyclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valacyclovir Sales by Application (2019-2030)
5.1.1 Global Valacyclovir Sales by Application (2019-2024)
5.1.2 Global Valacyclovir Sales by Application (2025-2030)
5.1.3 Global Valacyclovir Sales Market Share by Application (2019-2030)
5.2 Global Valacyclovir Revenue by Application (2019-2030)
5.2.1 Global Valacyclovir Revenue by Application (2019-2024)
5.2.2 Global Valacyclovir Revenue by Application (2025-2030)
5.2.3 Global Valacyclovir Revenue Market Share by Application (2019-2030)
5.3 Global Valacyclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Valacyclovir Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Mylan Pharmaceuticals
6.2.1 Mylan Pharmaceuticals Corporation Information
6.2.2 Mylan Pharmaceuticals Description and Business Overview
6.2.3 Mylan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Pharmaceuticals Valacyclovir Product Portfolio
6.2.5 Mylan Pharmaceuticals Recent Developments/Updates
6.3 Cobalt Laboratories (Allergan)
6.3.1 Cobalt Laboratories (Allergan) Corporation Information
6.3.2 Cobalt Laboratories (Allergan) Description and Business Overview
6.3.3 Cobalt Laboratories (Allergan) Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cobalt Laboratories (Allergan) Valacyclovir Product Portfolio
6.3.5 Cobalt Laboratories (Allergan) Recent Developments/Updates
6.4 Sorres Pharma
6.4.1 Sorres Pharma Corporation Information
6.4.2 Sorres Pharma Description and Business Overview
6.4.3 Sorres Pharma Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sorres Pharma Valacyclovir Product Portfolio
6.4.5 Sorres Pharma Recent Developments/Updates
6.5 Sivem Pharmaceuticals
6.5.1 Sivem Pharmaceuticals Corporation Information
6.5.2 Sivem Pharmaceuticals Description and Business Overview
6.5.3 Sivem Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sivem Pharmaceuticals Valacyclovir Product Portfolio
6.5.5 Sivem Pharmaceuticals Recent Developments/Updates
6.6 Remedy Repack
6.6.1 Remedy Repack Corporation Information
6.6.2 Remedy Repack Description and Business Overview
6.6.3 Remedy Repack Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Remedy Repack Valacyclovir Product Portfolio
6.6.5 Remedy Repack Recent Developments/Updates
6.7 Apotex Corporation
6.6.1 Apotex Corporation Corporation Information
6.6.2 Apotex Corporation Description and Business Overview
6.6.3 Apotex Corporation Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Corporation Valacyclovir Product Portfolio
6.7.5 Apotex Corporation Recent Developments/Updates
6.8 Auro Pharma
6.8.1 Auro Pharma Corporation Information
6.8.2 Auro Pharma Description and Business Overview
6.8.3 Auro Pharma Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Auro Pharma Valacyclovir Product Portfolio
6.8.5 Auro Pharma Recent Developments/Updates
6.9 Biomed Pharma
6.9.1 Biomed Pharma Corporation Information
6.9.2 Biomed Pharma Description and Business Overview
6.9.3 Biomed Pharma Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biomed Pharma Valacyclovir Product Portfolio
6.9.5 Biomed Pharma Recent Developments/Updates
6.10 PLIVA
6.10.1 PLIVA Corporation Information
6.10.2 PLIVA Description and Business Overview
6.10.3 PLIVA Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PLIVA Valacyclovir Product Portfolio
6.10.5 PLIVA Recent Developments/Updates
6.11 Marcan Pharmaceuticals
6.11.1 Marcan Pharmaceuticals Corporation Information
6.11.2 Marcan Pharmaceuticals Valacyclovir Description and Business Overview
6.11.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Marcan Pharmaceuticals Valacyclovir Product Portfolio
6.11.5 Marcan Pharmaceuticals Recent Developments/Updates
6.12 Jamp Pharma Corporatio
6.12.1 Jamp Pharma Corporatio Corporation Information
6.12.2 Jamp Pharma Corporatio Valacyclovir Description and Business Overview
6.12.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jamp Pharma Corporatio Valacyclovir Product Portfolio
6.12.5 Jamp Pharma Corporatio Recent Developments/Updates
6.13 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
6.13.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporation Information
6.13.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Description and Business Overview
6.13.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Product Portfolio
6.13.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments/Updates
6.14 Livzon Pharmaceutical Group
6.14.1 Livzon Pharmaceutical Group Corporation Information
6.14.2 Livzon Pharmaceutical Group Valacyclovir Description and Business Overview
6.14.3 Livzon Pharmaceutical Group Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Livzon Pharmaceutical Group Valacyclovir Product Portfolio
6.14.5 Livzon Pharmaceutical Group Recent Developments/Updates
6.15 Beijing Shuanglu Pharmaceutical
6.15.1 Beijing Shuanglu Pharmaceutical Corporation Information
6.15.2 Beijing Shuanglu Pharmaceutical Valacyclovir Description and Business Overview
6.15.3 Beijing Shuanglu Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing Shuanglu Pharmaceutical Valacyclovir Product Portfolio
6.15.5 Beijing Shuanglu Pharmaceutical Recent Developments/Updates
6.16 Sichuan Mingxin Pharmaceutical
6.16.1 Sichuan Mingxin Pharmaceutical Corporation Information
6.16.2 Sichuan Mingxin Pharmaceutical Valacyclovir Description and Business Overview
6.16.3 Sichuan Mingxin Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sichuan Mingxin Pharmaceutical Valacyclovir Product Portfolio
6.16.5 Sichuan Mingxin Pharmaceutical Recent Developments/Updates
6.17 Sichuan Baili Pharmaceutical
6.17.1 Sichuan Baili Pharmaceutical Corporation Information
6.17.2 Sichuan Baili Pharmaceutical Valacyclovir Description and Business Overview
6.17.3 Sichuan Baili Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sichuan Baili Pharmaceutical Valacyclovir Product Portfolio
6.17.5 Sichuan Baili Pharmaceutical Recent Developments/Updates
6.18 Sichuan Kelun Pharmaceutical
6.18.1 Sichuan Kelun Pharmaceutical Corporation Information
6.18.2 Sichuan Kelun Pharmaceutical Valacyclovir Description and Business Overview
6.18.3 Sichuan Kelun Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sichuan Kelun Pharmaceutical Valacyclovir Product Portfolio
6.18.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.19 Ansi Pharmaceutical
6.19.1 Ansi Pharmaceutical Corporation Information
6.19.2 Ansi Pharmaceutical Valacyclovir Description and Business Overview
6.19.3 Ansi Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Ansi Pharmaceutical Valacyclovir Product Portfolio
6.19.5 Ansi Pharmaceutical Recent Developments/Updates
6.20 Yichang Dongyangguang Changjiang Pharmaceutical
6.20.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
6.20.2 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Description and Business Overview
6.20.3 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Product Portfolio
6.20.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments/Updates
6.21 Shandong New Era Pharmaceutical
6.21.1 Shandong New Era Pharmaceutical Corporation Information
6.21.2 Shandong New Era Pharmaceutical Valacyclovir Description and Business Overview
6.21.3 Shandong New Era Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Shandong New Era Pharmaceutical Valacyclovir Product Portfolio
6.21.5 Shandong New Era Pharmaceutical Recent Developments/Updates
6.22 Shandong Luoxin Pharmaceutical Group
6.22.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.22.2 Shandong Luoxin Pharmaceutical Group Valacyclovir Description and Business Overview
6.22.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Product Portfolio
6.22.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.23 Guangdong Baike Pharmaceutical
6.23.1 Guangdong Baike Pharmaceutical Corporation Information
6.23.2 Guangdong Baike Pharmaceutical Valacyclovir Description and Business Overview
6.23.3 Guangdong Baike Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Guangdong Baike Pharmaceutical Valacyclovir Product Portfolio
6.23.5 Guangdong Baike Pharmaceutical Recent Developments/Updates
6.24 Chengdu Beite Pharmaceutical
6.24.1 Chengdu Beite Pharmaceutical Corporation Information
6.24.2 Chengdu Beite Pharmaceutical Valacyclovir Description and Business Overview
6.24.3 Chengdu Beite Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Chengdu Beite Pharmaceutical Valacyclovir Product Portfolio
6.24.5 Chengdu Beite Pharmaceutical Recent Developments/Updates
6.25 Kunming Yuanrui Pharmaceutical
6.25.1 Kunming Yuanrui Pharmaceutical Corporation Information
6.25.2 Kunming Yuanrui Pharmaceutical Valacyclovir Description and Business Overview
6.25.3 Kunming Yuanrui Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Kunming Yuanrui Pharmaceutical Valacyclovir Product Portfolio
6.25.5 Kunming Yuanrui Pharmaceutical Recent Developments/Updates
6.26 Yongxin Pharmaceutical Industry
6.26.1 Yongxin Pharmaceutical Industry Corporation Information
6.26.2 Yongxin Pharmaceutical Industry Valacyclovir Description and Business Overview
6.26.3 Yongxin Pharmaceutical Industry Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Yongxin Pharmaceutical Industry Valacyclovir Product Portfolio
6.26.5 Yongxin Pharmaceutical Industry Recent Developments/Updates
6.27 Hubei Huashitong Qianlong Pharmaceutical
6.27.1 Hubei Huashitong Qianlong Pharmaceutical Corporation Information
6.27.2 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Description and Business Overview
6.27.3 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Hubei Huashitong Qianlong Pharmaceutical Valacyclovir Product Portfolio
6.27.5 Hubei Huashitong Qianlong Pharmaceutical Recent Developments/Updates
6.28 Hubei Yikang Pharmaceutical Factory
6.28.1 Hubei Yikang Pharmaceutical Factory Corporation Information
6.28.2 Hubei Yikang Pharmaceutical Factory Valacyclovir Description and Business Overview
6.28.3 Hubei Yikang Pharmaceutical Factory Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.28.4 Hubei Yikang Pharmaceutical Factory Valacyclovir Product Portfolio
6.28.5 Hubei Yikang Pharmaceutical Factory Recent Developments/Updates
6.29 Hubei Keyi Pharmaceutical
6.29.1 Hubei Keyi Pharmaceutical Corporation Information
6.29.2 Hubei Keyi Pharmaceutical Valacyclovir Description and Business Overview
6.29.3 Hubei Keyi Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.29.4 Hubei Keyi Pharmaceutical Valacyclovir Product Portfolio
6.29.5 Hubei Keyi Pharmaceutical Recent Developments/Updates
6.30 Zhuhai Rundu Pharmaceutical
6.30.1 Zhuhai Rundu Pharmaceutical Corporation Information
6.30.2 Zhuhai Rundu Pharmaceutical Valacyclovir Description and Business Overview
6.30.3 Zhuhai Rundu Pharmaceutical Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.30.4 Zhuhai Rundu Pharmaceutical Valacyclovir Product Portfolio
6.30.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
6.31 Marcan Pharmaceuticals
6.31.1 Marcan Pharmaceuticals Corporation Information
6.31.2 Marcan Pharmaceuticals Valacyclovir Description and Business Overview
6.31.3 Marcan Pharmaceuticals Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.31.4 Marcan Pharmaceuticals Valacyclovir Product Portfolio
6.31.5 Marcan Pharmaceuticals Recent Developments/Updates
6.32 Jamp Pharma Corporatio
6.32.1 Jamp Pharma Corporatio Corporation Information
6.32.2 Jamp Pharma Corporatio Valacyclovir Description and Business Overview
6.32.3 Jamp Pharma Corporatio Valacyclovir Sales, Revenue and Gross Margin (2019-2024)
6.32.4 Jamp Pharma Corporatio Valacyclovir Product Portfolio
6.32.5 Jamp Pharma Corporatio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valacyclovir Industry Chain Analysis
7.2 Valacyclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valacyclovir Production Mode & Process
7.4 Valacyclovir Sales and Marketing
7.4.1 Valacyclovir Sales Channels
7.4.2 Valacyclovir Distributors
7.5 Valacyclovir Customers
8 Valacyclovir Market Dynamics
8.1 Valacyclovir Industry Trends
8.2 Valacyclovir Market Drivers
8.3 Valacyclovir Market Challenges
8.4 Valacyclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
GSK
Mylan Pharmaceuticals
Cobalt Laboratories (Allergan)
Sorres Pharma
Sivem Pharmaceuticals
Remedy Repack
Apotex Corporation
Auro Pharma
Biomed Pharma
PLIVA
Marcan Pharmaceuticals
Jamp Pharma Corporatio
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Livzon Pharmaceutical Group
Beijing Shuanglu Pharmaceutical
Sichuan Mingxin Pharmaceutical
Sichuan Baili Pharmaceutical
Sichuan Kelun Pharmaceutical
Ansi Pharmaceutical
Yichang Dongyangguang Changjiang Pharmaceutical
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Baike Pharmaceutical
Chengdu Beite Pharmaceutical
Kunming Yuanrui Pharmaceutical
Yongxin Pharmaceutical Industry
Hubei Huashitong Qianlong Pharmaceutical
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Zhuhai Rundu Pharmaceutical
Marcan Pharmaceuticals
Jamp Pharma Corporatio
听
听
*If Applicable.